The distinctive biology of cancer in adolescents and young adults
Top Cited Papers
- 1 April 2008
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 8 (4) , 288-298
- https://doi.org/10.1038/nrc2349
Abstract
One explanation for the relative lack of progress in treating cancer in adolescents and young adults is that the biology of malignant diseases in this age group is different than in younger and older persons, not only in the spectrum of cancers but also within individual cancer types and within the patient (host). Molecular, epidemiological and therapeutic outcome comparisons offer clues to this distinctiveness in most of the common cancers of adolescents and young adults. Translational and clinical research should not assume that the biology of cancers and patients is the same as in other age groups, and treatment strategies should be tailored to the differences.Keywords
This publication has 49 references indexed in Scilit:
- Acute Lymphoblastic LeukemiaPublished by Springer Nature ,2007
- Young Adult Oncology: The Patients and Their Survival ChallengesCA: A Cancer Journal for Clinicians, 2007
- Lack of Progress in Teen and Young Adult Cancers Concerns Researchers, Prompts StudyJNCI Journal of the National Cancer Institute, 2006
- How to Treat the Ewing's Family of Sarcomas in Adult PatientsThe Oncologist, 2006
- Treatment outcomes in adults with favorable histologic type Wilms tumor—an update from the National Wilms Tumor Study GroupInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of BoneNew England Journal of Medicine, 2003
- Localized Ewing Tumor of Bone: Final Results of the Cooperative Ewing’s Sarcoma Study CESS 86Journal of Clinical Oncology, 2001
- Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study GroupJournal of Clinical Oncology, 2000
- The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumoursAnnals of Oncology, 1997
- Prognostic factors and outcome in patients 21 years and under with colorectal carcinomaJournal of Pediatric Surgery, 1992